Our Development organization oversees the development of new medicines discovered by our researchers and partners.

We transform the lives of people by developing innovative and life-changing medicines in Immunology, Oncology, Hematology, Cardiovascular, Metabolic, Neurosciences, Respiratory, Global Health, new platform therapies like Cell and Gene therapies, and many other therapeutic areas.

160+

Projects in clinical development

500+

Ongoing clinical trials

80+

Major submissions planned for lead and new indications (2020-2022)

Novel therapy/ medicine’s journey starts from basic research (Biology, Chemistry) moves through Translational Research & Development (Clinical Trials phases) and ultimately to commercial use (once product is approved for commercial use).

The cross-functional research and development strategy and high-level plan for a specific asset (i.e. new medicine) development is supported by various units located in Hyderabad - Clinical Development and Analytics, Global Development Operation, Chief Medical Office/Patient Safety Function, Global Development Quality (GDQ) Function, Regulatory Function, Translational Research and Development (Technical and Clinical Support) and Portfolio, Strategy and Management - Global Program Management.